Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype
Alexandre Willaume(Périnatalité & Risques Toxiques), Laurent Pascal(Groupe Hospitalier de l'Institut Catholique de Lille), Benjamin Carpentier, Philippe Gosset(Groupe Hospitalier de l'Institut Catholique de Lille), Alban Bailliez(Groupe Hospitalier de l'Institut Catholique de Lille), Mourtaza Karimdjee(Université de Lille), Bénédicte Hivert(Hôpital Saint-Vincent-de-Paul), Sandy Amorim(Hôpital Saint-Vincent-de-Paul), Emmanuelle Bourgeois-Petit(Hôpital Saint-Vincent-de-Paul)
Cited by 0
Related Papers
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
|The Lancet|2023|181
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
|Frontiers in Oncology|2019|80
Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses
|Journal of Neurology|2020|55
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
|Blood Advances|2021|51
A new role of glutathione peroxidase 4 during human erythroblast enucleation
|Blood Advances|2020|34